US Bancorp’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $32M | Sell |
353,529
-2,239
| -0.6% | -$188K | 0.03% | 262 |
|
|
2026
Q1 | $28.5M | Sell |
355,768
-7,608
| -2% | -$627K | 0.03% | 262 |
|
|
2025
Q4 | $31M | Sell |
363,376
-15,402
| -4% | -$1.26M | 0.04% | 256 |
|
|
2025
Q3 | $29.5M | Sell |
378,778
-35,677
| -9% | -$2.79M | 0.03% | 277 |
|
|
2025
Q2 | $32.4M | Sell |
414,455
-46,944
| -10% | -$3.5M | 0.04% | 257 |
|
|
2025
Q1 | $33.4M | Sell |
461,399
-186,577
| -29% | -$13.4M | 0.04% | 246 |
|
|
2024
Q4 | $48M | Sell |
647,976
-59,755
| -8% | -$4.18M | 0.06% | 200 |
|
|
2024
Q3 | $46.7M | Sell |
707,731
-36,415
| -5% | -$2.65M | 0.06% | 201 |
|
|
2024
Q2 | $68.7M | Sell |
744,146
-18,321
| -2% | -$1.62M | 0.09% | 162 |
|
|
2024
Q1 | $72.9M | Sell |
762,467
-65,373
| -8% | -$5.49M | 0.1% | 158 |
|
|
2023
Q4 | $63.1M | Sell |
827,840
-22,417
| -3% | -$1.56M | 0.09% | 163 |
|
|
2023
Q3 | $58.9M | Buy |
850,257
+5,409
| +0.6% | +$435K | 0.1% | 167 |
|
|
2023
Q2 | $79.7M | Sell |
844,848
-7,355
| -0.9% | -$639K | 0.13% | 142 |
|
|
2023
Q1 | $70.5M | Sell |
852,203
-1,042
| -0.1% | -$81.9K | 0.12% | 150 |
|
|
2022
Q4 | $63.7M | Buy |
853,245
+104,052
| +14% | +$8.02M | 0.11% | 151 |
|
|
2022
Q3 | $61.9M | Sell |
749,193
-19,454
| -3% | -$1.87M | 0.13% | 142 |
|
|
2022
Q2 | $73.1M | Buy |
768,647
+19,743
| +3% | +$2.04M | 0.14% | 134 |
|
|
2022
Q1 | $88.2M | Buy |
748,904
+38,770
| +5% | +$4.35M | 0.15% | 127 |
|
|
2021
Q4 | $92M | Buy |
710,134
+5,474
| +0.8% | +$639K | 0.15% | 124 |
|
|
2021
Q3 | $79.8M | Sell |
704,660
-27,280
| -4% | -$3.11M | 0.15% | 127 |
|
|
2021
Q2 | $75.8M | Sell |
731,940
-382
| -0.1% | -$36K | 0.14% | 139 |
|
|
2021
Q1 | $61.3M | Buy |
732,322
+11,207
| +2% | +$947K | 0.12% | 146 |
|
|
2020
Q4 | $65.8M | Buy |
721,115
+23,718
| +3% | +$1.97M | 0.14% | 137 |
|
|
2020
Q3 | $55.7M | Sell |
697,397
-34,658
| -5% | -$2.7M | 0.14% | 142 |
|
|
2020
Q2 | $50.6M | Buy |
732,055
+26,107
| +4% | +$1.86M | 0.13% | 145 |
|
|
2020
Q1 | $44.4M | Sell |
705,948
-23,043
| -3% | -$1.66M | 0.14% | 140 |
|
|
2019
Q4 | $56.7M | Sell |
728,991
-52,428
| -7% | -$4.09M | 0.14% | 137 |
|
|
2019
Q3 | $57.3M | Sell |
781,419
-44,808
| -5% | -$3.15M | 0.16% | 132 |
|
|
2019
Q2 | $50.9M | Sell |
826,227
-29,301
| -3% | -$1.77M | 0.14% | 142 |
|
|
2019
Q1 | $54.6M | Sell |
855,528
-17,253
| -2% | -$985K | 0.16% | 127 |
|
|
2018
Q4 | $44.6M | Sell |
872,781
-20,865
| -2% | -$1.06M | 0.14% | 138 |
|
|
2018
Q3 | $51.9M | Sell |
893,646
-51,498
| -5% | -$2.52M | 0.15% | 136 |
|
|
2018
Q2 | $45.9M | Sell |
945,144
-50,496
| -5% | -$2.36M | 0.14% | 145 |
|
|
2018
Q1 | $46.3M | Sell |
995,640
-31,311
| -3% | -$1.36M | 0.14% | 141 |
|
|
2017
Q4 | $38.6M | Buy |
1,026,951
+194,031
| +23% | +$7.12M | 0.12% | 160 |
|
|
2017
Q3 | $30.4M | Buy |
832,920
+112,290
| +16% | +$4.28M | 0.1% | 178 |
|
|
2017
Q2 | $28.4M | Buy |
720,630
+71,238
| +11% | +$2.6M | 0.09% | 185 |
|
|
2017
Q1 | $20.4M | Buy |
649,392
+268,818
| +71% | +$8.42M | 0.07% | 218 |
|
|
2016
Q4 | $11.9M | Buy |
380,574
+182,505
| +92% | +$5.91M | 0.04% | 309 |
|
|
2016
Q3 | $7.96M | Buy |
198,069
+1,371
| +0.7% | +$51.6K | 0.03% | 372 |
|
|
2016
Q2 | $6.54M | Sell |
196,698
-2,037
| -1% | -$69.7K | 0.02% | 400 |
|
|
2016
Q1 | $5.84M | Sell |
198,735
-56,121
| -22% | -$1.55M | 0.02% | 419 |
|
|
2015
Q4 | $6.71M | Buy |
254,856
+1,392
| +0.5% | +$36.1K | 0.03% | 395 |
|
|
2015
Q3 | $6.01M | Buy |
253,464
+6,540
| +3% | +$158K | 0.03% | 415 |
|
|
2015
Q2 | $5.86M | Sell |
246,924
-8,034
| -3% | -$181K | 0.02% | 434 |
|
|
2015
Q1 | $6.05M | Buy |
254,958
+68,958
| +37% | +$1.55M | 0.02% | 421 |
|
|
2014
Q4 | $3.95M | Buy |
186,000
+9,336
| +5% | +$188K | 0.02% | 496 |
|
|
2014
Q3 | $3.01M | Sell |
176,664
-17,694
| -9% | -$279K | 0.01% | 552 |
|
|
2014
Q2 | $2.78M | Sell |
194,358
-5,496
| -3% | -$74.5K | 0.01% | 594 |
|
|
2014
Q1 | $2.47M | Sell |
199,854
-18,084
| -8% | -$209K | 0.01% | 621 |
|
|
2013
Q4 | $2.39M | Sell |
217,938
-3,006
| -1% | -$33.9K | 0.01% | 607 |
|
|
2013
Q3 | $2.56M | Buy |
220,944
+24,360
| +12% | +$285K | 0.01% | 553 |
|
|
2013
Q2 | $2.2M | Buy |
+196,584
| New | +$2.33M | 0.01% | 578 |
|
Other funds holding EW
US Bancorp's EW Position: Q2 2026 in Review
US Bancorp reduced its Edwards Lifesciences (EW) stake by 0.63% in Q2 2026, selling an estimated $188K and leaving 353,529 shares worth $32M. The position accounts for 0.03% of the portfolio, ranked #262.
US Bancorp first reported a position in EW in Q2 2013 and has held it in 53 quarters since. The position peaked at $92M in Q4 2021. 1,325 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- US Bancorp held 353,529 shares of Edwards Lifesciences worth $32M as of Q2 2026.
- US Bancorp sold 2,239 Edwards Lifesciences shares in Q2 2026, an estimated $188K.
- Edwards Lifesciences made up 0.03% of US Bancorp's portfolio in Q2 2026, its #262 holding.
- US Bancorp first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 53 quarters since.
- US Bancorp's Edwards Lifesciences position peaked at $92M in Q4 2021.
- 1,325 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.